![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 35, 26935-26943, September 1, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The homophilic binding of extracellular domains
of membrane-bound immunoglobulin superfamily (IgSF) molecules is often
required for intercellular adhesion and signaling. Carcinoembryonic
antigen (CEA), a member of the IgSF, is a widely used tumor marker that functions in vitro as a homotypic intercellular adhesion
molecule. CEA has also been shown to contribute to tumorigenicity by
inhibiting cellular differentiation, an effect that requires the
homophilic binding of its extracellular domains. It was of interest,
therefore, to identify small subdomain sequences in CEA that could
serve as a focus in the design of peptides that disrupt CEA-mediated intercellular adhesion. Three subdomains in the N-terminal domain of
CEA, identified by site-directed deletions and point mutations, were
shown to be required for intercellular adhesion. Cyclized peptides
representing two of these subdomains, 42NRQII and
80QNDTG, were found to be effective in blocking
CEA-mediated cellular aggregation when added to CEA-expressing
transfectants in suspension. Intermolecular binding involving each of
these subdomains is therefore essential for intercellular adhesion and
cannot be compensated for by known binding contributions of other
regions in the CEA molecule. In further support of this assumption, the
binding epitope of an anti-CEA monoclonal antibody (monoclonal antibody
A20) known to block CEA-mediated adhesion, was shown to bridge two of
the three required subdomains: 42NRQII and
30GYSWYK.
Self Recognition in the Ig Superfamily
IDENTIFICATION OF PRECISE SUBDOMAINS IN CARCINOEMBRYONIC ANTIGEN
REQUIRED FOR INTERCELLULAR ADHESION*
§,
¶,
,
,
, and
§**
McGill Cancer Centre and the Departments of
§ Biochemistry and ¶ Pharmacology & Therapeutics,
McGill University, 3655 Promenade Sir-William-Osler, Montréal,
Québec H3G 1Y6, Canada and the
Shriners Hospital for
Children, 1529 Cedar Ave., Montréal, Québec H3G 1A6,
Canada
*
This work was supported by grants from the National Cancer
Institute of Canada and the Medical Research Council of Canada.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
N. Korotkova, E. Cota, Y. Lebedin, S. Monpouet, J. Guignot, A. L. Servin, S. Matthews, and S. L. Moseley A Subfamily of Dr Adhesins of Escherichia coli Bind Independently to Decay-accelerating Factor and the N-domain of Carcinoembryonic Antigen J. Biol. Chem., September 29, 2006; 281(39): 29120 - 29130. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Blumenthal, H. J. Hansen, and D. M. Goldenberg Inhibition of Adhesion, Invasion, and Metastasis by Antibodies Targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen) Cancer Res., October 1, 2005; 65(19): 8809 - 8817. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Markel, R. Gruda, H. Achdout, G. Katz, M. Nechama, R. S. Blumberg, R. Kammerer, W. Zimmermann, and O. Mandelboim The Critical Role of Residues 43R and 44Q of Carcinoembryonic Antigen Cell Adhesion Molecules-1 in the Protection from Killing by Human NK Cells J. Immunol., September 15, 2004; 173(6): 3732 - 3739. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Comegys, S.-H. Lin, D. Rand, D. Britt, D. Flanagan, H. Callanan, K. Brilliant, and D. C. Hixson Two Variable Regions in Carcinoembryonic Antigen-related Cell Adhesion Molecule1 N-terminal Domains Located in or Next to Monoclonal Antibody and Adhesion Epitopes Show Evidence of Recombination in Rat but Not in Human J. Biol. Chem., August 13, 2004; 279(33): 35063 - 35078. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Taheri, H. U. Saragovi, and C. P. Stanners The Adhesion and Differentiation-inhibitory Activities of the Immunoglobulin Superfamily Member, Carcinoembryonic Antigen, Can Be Independently Blocked J. Biol. Chem., April 18, 2003; 278(17): 14632 - 14639. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. L. Berinstein Carcinoembryonic Antigen as a Target for Therapeutic Anticancer Vaccines: A Review J. Clin. Oncol., April 15, 2002; 20(8): 2197 - 2207. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuroki, H. Abe, T. Imakiirei, S. Liao, H. Uchida, Y. Yamauchi, S. Oikawa, and M. Kuroki Identification and comparison of residues critical for cell-adhesion activities of two neutrophil CD66 antigens, CEACAM6 and CEACAM8 J. Leukoc. Biol., October 1, 2001; 70(4): 543 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Soeth, T. Wirth, H.-J. List, S. Kumbhani, A. Petersen, M. Neumaier, F. Czubayko, and H. Juhl Controlled Ribozyme Targeting Demonstrates an Antiapoptotic Effect of Carcinoembryonic Antigen in HT29 Colon Cancer Cells Clin. Cancer Res., July 1, 2001; 7(7): 2022 - 2030. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |